Urine arsenic concentration and obstructive pulmonary disease in the U.S. Population

Author： Amster Eric   Cho Jang Ik   Christiani David  

Publisher： Taylor & Francis Ltd

ISSN： 1087-2620

Source： Journal of Toxicology and Environmental Health, Vol.74, Iss.11, 2011-01, pp. : 716-727

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Association between C-reactive Protein Concentration and Chronic Obstructive Pulmonary Disease: a Systematic Review and Meta-analysis

By Zhang Y   Bunjhoo H   Xiong W   Xu Y   Yang D  

The Journal of International Medical Research, Vol. 40, Iss. 5, 2012-09 ,pp. : 1629-1635

Field House Publishing

Access to resources Recommend Favorite

Indacaterol: In Chronic Obstructive Pulmonary Disease

By Moen Marit D.  

Drugs, Vol. 70, Iss. 17, 2010-12 ,pp. : 2269-2280

Adis International

Access to resources Recommend Favorite

Roflumilast: In Chronic Obstructive Pulmonary Disease

By Sanford Mark  

Drugs, Vol. 70, Iss. 12, 2010-08 ,pp. : 1615-1627

Adis International

Access to resources Recommend Favorite

Pharmacogenetics of chronic obstructive pulmonary disease

By Hizawa Nobuyuki  

Pharmacogenomics, Vol. 14, Iss. 10, 2013-07 ,pp. : 1215-1225

Future Medicine

Access to resources Recommend Favorite

Aclidinium: In Chronic Obstructive Pulmonary Disease

By Frampton James E.  

Drugs, Vol. 72, Iss. 15, 2012-10 ,pp. : 1999-2011

Adis International

Access to resources Recommend Favorite